Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.30 EUR
−31.37 M EUR
2.15 M EUR
119.47 M
About RENALYTIX PLC ORD GBP0.0025
Sector
Industry
CEO
James Renwick McCullough
Website
Headquarters
New York
Founded
2018
ISIN
GB00BYWL4Y04
FIGI
BBG00VQQNMN6
Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2O9 is 0.08 EUR — it has increased by 0.62% in the past 24 hours. Watch RENALYTIX PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange RENALYTIX PLC stocks are traded under the ticker 2O9.
2O9 stock has risen by 29.60% compared to the previous week, the month change is a 51.40% rise, over the last year RENALYTIX PLC has showed a −83.26% decrease.
2O9 stock is 27.56% volatile and has beta coefficient of 1.63. Track RENALYTIX PLC stock price on the chart and check out the list of the most volatile stocks — is RENALYTIX PLC there?
Today RENALYTIX PLC has the market capitalization of 18.35 M, it has increased by 0.41% over the last week.
Yes, you can track RENALYTIX PLC financials in yearly and quarterly reports right on TradingView.
RENALYTIX PLC is going to release the next earnings report on Nov 27, 2024. Keep track of upcoming events with our Earnings Calendar.
2O9 earnings for the last quarter are −0.01 EUR per share, whereas the estimation was −0.03 EUR resulting in a 45.45% surprise. The estimated earnings for the next quarter are −0.02 EUR per share. See more details about RENALYTIX PLC earnings.
RENALYTIX PLC revenue for the last quarter amounts to 540.56 K EUR, despite the estimated figure of 723.54 K EUR. In the next quarter, revenue is expected to reach 808.33 K EUR.
2O9 net income for the last quarter is −6.62 M EUR, while the quarter before that showed −7.14 M EUR of net income which accounts for 7.37% change. Track more RENALYTIX PLC financial stats to get the full picture.
No, 2O9 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RENALYTIX PLC EBITDA is −26.76 M EUR, and current EBITDA margin is −1.25 K%. See more stats in RENALYTIX PLC financial statements.
Like other stocks, 2O9 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RENALYTIX PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RENALYTIX PLC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RENALYTIX PLC stock shows the sell signal. See more of RENALYTIX PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.